These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


153 related items for PubMed ID: 321166

  • 1. Levamisole and human lymphocyte surface markers.
    Wybran J, Govaerts A.
    Clin Exp Immunol; 1977 Feb; 27(2):319-21. PubMed ID: 321166
    [Abstract] [Full Text] [Related]

  • 2. Study of lymphocyte subpopulations in patients with systemic lupus erythematosus. In vitro effect of levamisole on T-lymphocyte population.
    Pozsonyi T, Jakab L, Fehér J.
    Allergol Immunopathol (Madr); 1980 Feb; 8(5):553-8. PubMed ID: 6970515
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The influence of levamisole in vitro on lymphocytes from an immunodeficient patient].
    Conti P, Cifone MG, Alesse E, Bruno G, Mantovanelli M, Rossi A.
    Boll Soc Ital Biol Sper; 1980 May 30; 56(10):981-5. PubMed ID: 6969598
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Action of levamisole on lymphocytic reactivity in naso-laryngeal carcinoma].
    Stivala F, Malannino N, Cordopatri F, Campo M.
    Boll Soc Ital Biol Sper; 1980 Aug 30; 56(16):1687-93. PubMed ID: 6970042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levamisole in the treatment of Hodgkin's disease.
    Berényi E, Kávai M, Szabolcsi M, Szegedi G.
    Acta Med Acad Sci Hung; 1979 Aug 30; 36(2):177-85. PubMed ID: 317549
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. In vitro stimulation of murine lymphoid cell cultures by levamisole.
    Merluzzi VJ, Badger AM, Kaiser CW, Cooperband SR.
    Clin Exp Immunol; 1975 Dec 30; 22(3):486-92. PubMed ID: 1083786
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP, Lindström FD, Williams RC.
    J Clin Invest; 1973 Dec 30; 52(12):3046-56. PubMed ID: 4584345
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B, Biniaminov M, Shoham C, Rosenthal E.
    N Engl J Med; 1976 Apr 08; 294(15):809-11. PubMed ID: 1082545
    [Abstract] [Full Text] [Related]

  • 20. The effect of levamisole on E-rosette formation by trypsinized lymphocytes.
    Lomnitzer R, Rabson AR.
    Clin Exp Immunol; 1978 Sep 08; 33(3):499-502. PubMed ID: 310743
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.